- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Global Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership
Results
94
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
94 companies
Ascentage Pharma Group International
Market Cap: HK$30.2b
A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.
6855
HK$82.35
7D
-1.4%
1Y
144.4%
Pharma Mar
Market Cap: €1.5b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.
PHM
€85.00
7D
4.9%
1Y
109.2%
Oscotec
Market Cap: ₩1.5t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩38,200.00
7D
13.4%
1Y
-4.1%
AprilBioLtd
Market Cap: ₩556.3b
AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.
A397030
₩24,650.00
7D
12.0%
1Y
11.5%
Marinomed Biotech
Market Cap: €35.6m
A biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally.
MARI
€20.00
7D
0.3%
1Y
269.0%
RemeGen
Market Cap: HK$55.4b
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.
9995
HK$96.75
7D
5.3%
1Y
687.9%
Acrux
Market Cap: AU$5.3m
Engages in the development and commercialization of generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally.
ACR
AU$0.013
7D
-13.3%
1Y
-78.7%
ALTEOGEN
Market Cap: ₩24.7t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩462,500.00
7D
4.5%
1Y
42.1%
Bonesupport Holding
Market Cap: SEK 20.5b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 312.00
7D
5.4%
1Y
4.6%
MedinCell
Market Cap: €559.7m
A pharmaceutical company, develops long acting injectables in various therapeutic areas in France.
MEDCL
€16.92
7D
-2.5%
1Y
-6.3%
Xbrane Biopharma
Market Cap: SEK 714.9m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANE
SEK 0.28
7D
7.8%
1Y
113.1%
Akeso
Market Cap: HK$139.8b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$155.80
7D
-7.8%
1Y
217.6%
Jiangsu Sinopep-Allsino Biopharmaceutical
Market Cap: CN¥13.6b
A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.
688076
CN¥43.01
7D
0.5%
1Y
3.7%
Egetis Therapeutics
Market Cap: SEK 1.8b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 5.00
7D
-5.1%
1Y
-12.0%
EZZ Life Science Holdings
Market Cap: AU$100.5m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.
EZZ
AU$2.13
7D
-13.8%
1Y
-21.1%
Mesoblast
Market Cap: AU$2.6b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$2.02
7D
-17.9%
1Y
89.7%
Guard Therapeutics International
Market Cap: SEK 455.8m
A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.
GUARD
SEK 22.60
7D
1.3%
1Y
-21.5%
Macrogen
Market Cap: ₩165.1b
Provides precision medicine and bio-engineering healthcare services in Korea and internationally.
A038290
₩15,230.00
7D
-3.1%
1Y
-17.6%
Aether Industries
Market Cap: ₹98.9b
Produces and sells advanced intermediates and specialty chemicals in India and internationally.
AETHER
₹745.95
7D
1.4%
1Y
-16.2%
Clinuvel Pharmaceuticals
Market Cap: AU$522.8m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$10.43
7D
-23.9%
1Y
-32.4%
Ocumension Therapeutics
Market Cap: HK$7.5b
Operates as an ophthalmic pharmaceutical platform company in the People's Republic of China.
1477
HK$9.16
7D
-6.8%
1Y
73.2%
PharmaResources (Shanghai)
Market Cap: CN¥5.2b
Operates as a CRO, CDMO, and CMO service provider of drug discovery in China.
301230
CN¥37.52
7D
-6.8%
1Y
87.2%
Boji Medical TechnologyLtd
Market Cap: CN¥4.2b
Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.
300404
CN¥10.85
7D
-4.6%
1Y
48.6%
Zhejiang Jolly PharmaceuticalLTD
Market Cap: CN¥12.8b
Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.
300181
CN¥18.52
7D
-6.3%
1Y
44.0%
OS Therapies
Market Cap: US$76.2m
A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.
OSTX
US$2.22
7D
-4.7%
1Y
-43.9%
Corcept Therapeutics
Market Cap: US$7.3b
Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
CORT
US$71.38
7D
2.6%
1Y
108.3%
Grace Therapeutics
Market Cap: US$41.9m
Engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
GRCE
US$2.99
7D
-7.0%
1Y
17.0%
Aelis Farma
Market Cap: €15.2m
A clinical-stage biopharmaceutical company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders in France.
AELIS
€1.12
7D
-5.9%
1Y
-90.2%
Eton Pharmaceuticals
Market Cap: US$464.2m
A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
ETON
US$17.19
7D
-1.5%
1Y
273.7%
Senores Pharmaceuticals
Market Cap: ₹32.1b
Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.
SENORES
₹696.50
7D
-1.5%
1Y
n/a
Shanghai Rightongene Biotechnology
Market Cap: CN¥1.6b
Shanghai Rightongene Biotechnology Co., Ltd.
688217
CN¥28.81
7D
-16.2%
1Y
98.4%
Caliway Biopharmaceuticals
Market Cap: NT$359.1b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$231.50
7D
16.3%
1Y
279.5%
Shanghai OPM Biosciences
Market Cap: CN¥6.0b
Provides cell culture media and CDMO services in China and internationally.
688293
CN¥52.75
7D
-6.5%
1Y
97.9%
Devyser Diagnostics
Market Cap: SEK 2.5b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 151.60
7D
3.0%
1Y
35.4%
Faron Pharmaceuticals Oy
Market Cap: UK£229.5m
Operates as a clinical stage drug discovery and development company.
FARN
UK£2.05
7D
-7.9%
1Y
-7.2%
Labiana Health
Market Cap: €31.0m
Develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, and internationally.
LAB
€4.40
7D
10.0%
1Y
41.9%